Pharmagreen Biotech Inc. (PHBI) Financial Statements (2026 and earlier)

Company Profile

Business Address 2987 BLACKBEAR COURT
COQUITLAM, BC V3E3A2
State of Incorp. NV
Fiscal Year End September 30
Industry (SIC) 4581 - Airports, Flying Fields, and Airport Terminal Services (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)
Annual | Quarterly

6/30/2023
Q3
3/31/2023
Q2
12/31/2022
Q1
9/30/2022
Q4
6/30/2022
Q3
3/31/2022
Q2
12/31/2021
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7,38624,9648,01624,2623,04510,474
Cash and cash equivalent7,38624,9648,01624,2623,04510,474
Receivables569465 31670 
Inventory, net of allowances, customer advances and progress billings9,543     
Inventory9,543     
Other undisclosed current assets56,640     
Total current assets:74,13825,4298,01624,5783,11510,474
Noncurrent Assets
Other undisclosed noncurrent assets88,850     
Total noncurrent assets:88,850     
Other undisclosed assets  186,239200,955166,592195,288347,279
TOTAL ASSETS:162,988211,668208,971191,170198,403357,753
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:799,612783,212724,876731,287721,228699,454
Interest and dividends payable✕✕✕✕✕98,67488,239
Accounts payable690,714684,679644,970621,933622,554611,215
Accrued liabilities      8,000
Other undisclosed accounts payable and accrued liabilities108,89898,53379,906109,354 (8,000)
Debt185,818314,411219,115260,834260,834230,834
Derivative instruments and hedges, liabilities172,092110,443271,394306,591 237,729
Due to related parties✕90,675665,293641,915644,568712,535673,680
Other undisclosed current liabilities812,29045,48354,84747,411862,43059,258
Total current liabilities:2,060,4871,918,8421,912,1471,990,6912,557,0271,900,955
Noncurrent Liabilities
Long-term debt and lease obligation   29,252 43,8269,633
Long-term debt, excluding current maturities   29,252 43,8269,633
Liabilities, other than long-term debt  90,58490,22192,692  
Due to related parties✕✕90,58490,22192,692  
Other undisclosed noncurrent liabilities90,675  45,525 31,604
Total noncurrent liabilities:90,67590,584119,473138,21743,82641,237
Total liabilities:2,151,1622,009,4262,031,6202,128,9082,600,8531,942,192
Equity
Equity, attributable to parent, including:(1,941,489)(1,751,073)(1,822,649)(1,891,080)(2,402,450)(1,584,439)
Preferred stock10101010109,768,572
Common stock454,761454,761442,261424,421397,221385,171
Common stock, value, subscriptions   1,130   
Additional paid in capital10,326,77710,326,77710,261,77710,117,7229,991,72210
Accumulated other comprehensive income (loss)79,21481,64893,75312,574(28,311)(10,841)
Accumulated deficit(12,802,251)(12,614,269)(12,574,895)(12,464,499)(12,716,434)(11,680,693)
Other undisclosed equity, attributable to parent   (46,685)18,692(46,658)(46,658)
Equity, attributable to noncontrolling interest(46,685)(46,685) (46,658)  
Total equity:(1,988,174)(1,797,758)(1,822,649)(1,937,738)(2,402,450)(1,584,439)
TOTAL LIABILITIES AND EQUITY:162,988211,668208,971191,170198,403357,753

Income Statement (P&L) (USD)
Annual | Quarterly

6/30/2023
Q3
3/31/2023
Q2
12/31/2022
Q1
9/30/2022
Q4
6/30/2022
Q3
3/31/2022
Q2
12/31/2021
Q1
Revenues963160,95135,197510,066 234,274
Gain (loss) on disposition of assets for financial service operations(17,149)160,95135,197510,066(563,917)234,274
Cost of revenue
(Cost of Product and Service Sold)		(985)     
Gross profit:(22)160,95135,197510,066 234,274
Operating expenses(120,227)(181,093)(197,755)(241,218)(458,860)(203,660)
Other undisclosed operating income (loss) (67,733)(160,951)(35,197)(510,066)563,917(234,274)
Operating loss:(187,982)(181,093)(197,755)(241,218)(458,860)(203,660)
Nonoperating income (expense)(67,016)141,71987,332493,153(576,881)222,384
Other nonoperating income (expense)(67,733)141,719 493,153  
Interest and debt expense(8,129)(8,311)2,139(10,757)(10,071)(10,091)
Income (loss) from continuing operations:(263,127)(47,685)(108,284)241,178(1,045,812)8,633
Income (loss) before gain (loss) on sale of properties:✕✕✕✕241,178(1,045,812)8,633
Other undisclosed net income  87,05928,780   
Net income (loss):(263,127)39,374(79,504)241,178(1,045,812)8,633
Net income attributable to noncontrolling interest      
Other undisclosed net income (loss) attributable to parent (78,748)(30,919)10,75710,07110,091
Net income (loss) available to common stockholders, diluted:(263,127)(39,374)(110,423)251,935(1,035,741)18,724

Comprehensive Income (USD)
Annual | Quarterly

6/30/2023
Q3
3/31/2023
Q2
12/31/2022
Q1
9/30/2022
Q4
6/30/2022
Q3
3/31/2022
Q2
12/31/2021
Q1
Net income (loss):(263,127)39,374(79,504)241,178(1,045,812)8,633
Comprehensive income (loss):(263,127)39,374(79,504)241,178(1,045,812)8,633
Comprehensive income, net of tax, attributable to noncontrolling interest      
Other undisclosed comprehensive income (loss), net of tax, attributable to parent  (90,853)(1,029,480)51,642(7,399)7,628
Comprehensive income (loss), net of tax, attributable to parent:(263,127)(51,479)(1,108,984)292,820(1,053,211)16,261

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: